MKKGY Merck KGaA

$31.58

Merck KGaA (MKKGY) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $0.47 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -5.0% since its last earnings release on August 6, 2026.

Merck KGaA Missed Consensus Estimates
Thursday, August 6, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · Before Open
Earnings Whisper
-
vs $0.47
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $32.96

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Merck KGaA

Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Sector

Healthcare

Industry

Drug Manufacturers/Other